Fatty acid synthase has been reported to be highly expressed in a variety of cancers, including cancers of the prostate, ovary, lung, colon, and breast12, while MDM2, cyclin D1 and Aurora-A play critical roles in p53 regulation, cell cycle progression and mitotic events, respectively9,10,13. The gene discussed is MDM2; the disease is prostate cancer.